The mechanism underlying the elevated COVID-19 mortality in patients with diabetes may be explained by the increase in chronic inflammatory markers, such as C reactive protein, interleukin 6, interleukin 10, and tumor necrosis factor-α, which promote susceptibility to COVID-19 [27]. This evidence concerns the gene IL10 and diabetes mellitus.